8-K: Nukkleus Inc. Secures $246,145 Investment Through Share Sale to ProETP DAC

Nukkleus Inc. has finalized a securities purchase agreement with ProETP DAC, issuing 138,556 shares for $246,145 to bolster its working capital.

Summary

• Nukkleus Inc. entered into a securities purchase agreement with NUKK TRACKER NOTES CH1108678926 / 23714, a series of notes issued by ProETP DAC.
• The agreement involves the sale of 138,556 shares of Nukkleus common stock at a price of $1.7765 per share.
• The total purchase price for the shares was $246,145.
• The shares were sold at a 5% discount from the closing share price on November 15th.
• The investor is purchasing the units as securities assets to be held on its behalf in relation to Series 24 under its respective custody account with number 23714.
• Nukkleus had already received $231,882 from the investor prior to the agreement.
• The company will use the proceeds for general corporate needs and working capital, including paying existing payables.
• The agreement includes standard representations and warranties from both parties, as well as indemnification clauses.

Sentiment

Score: 7

Explanation: The document indicates a positive development for the company as it secures additional funding. However, the lack of specific details on the company's financial health and future plans prevents a higher score.

Positives

• Nukkleus Inc. successfully raised $246,145 in capital.
• The investment will provide the company with additional working capital.
• The agreement includes standard protections for both parties, such as representations, warranties, and indemnification.

Risks

• The company's reliance on a single investor for this capital raise could pose a risk if the relationship deteriorates.
• The agreement includes indemnification clauses that could expose the company to potential liabilities if representations and warranties are breached.
• The company's use of proceeds for general corporate needs and working capital may not be sufficient to address all of its financial challenges.

Future Outlook

The company intends to use the proceeds from the share sale for general corporate needs and working capital, including paying existing payables.

Management Comments

• The company will use the Purchase Price for its general corporate needs and working capital including to pay its existing Payables.

Industry Context

This transaction is a common method for companies to raise capital, particularly for smaller firms seeking to fund operations or growth. The use of a discount to the market price is a typical incentive for investors in such private placements.

Comparison to Industry Standards

• The 5% discount on the share price is within the typical range for private placements of this nature.
• The use of a securities purchase agreement is a standard practice for these types of transactions.
• The inclusion of representations, warranties, and indemnification clauses is consistent with industry norms for private placements.
• The investor is a series of notes issued by ProETP DAC, which is a common structure for investment vehicles.

Stakeholder Impact

• Shareholders may see a slight dilution of their ownership due to the issuance of new shares.
• The company's employees may benefit from the improved financial stability provided by the capital raise.
• Creditors may be paid down with the new capital.

Next Steps

• The company will deliver stock certificates or book-entry confirmations to the investor within 14 business days of receiving the subscription proceeds.
• The company will use the funds for general corporate needs and working capital.

Key Dates

Keywords

securities purchase agreement, common stock, capital raise, investment, Nukkleus Inc., ProETP DAC, share sale, working capital